Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Kevin Andrew Robbins bought 7,100 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the transaction, the director owned 33,333 shares in the company, valued at approximately $138,998.61. This represents a 27.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Mannatech Trading Up 11.9%
NASDAQ:MTEX opened at $4.42 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.59 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $8.53 million, a PE ratio of -0.66 and a beta of 0.61. The firm’s 50 day moving average is $5.52 and its 200 day moving average is $7.24. Mannatech, Incorporated has a 12 month low of $3.80 and a 12 month high of $12.45.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.49 EPS for the quarter. The company had revenue of $24.92 million for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Further Reading
- Five stocks we like better than Mannatech
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
